Longeveron

Public

United StatesHealthcarehttps://longeveron.com/

Longeveron is now publicly traded

The data on this page reflects Longeveron's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Mar 25, 2026

Total Funding Raised

$15.89M

Company Overview

Longeveron is a clinical-stage biotechnology company that develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan.

Sector

Healthcare

AI Layer

Non-AI

Keywords

cell therapyregenerative medicineLaromestrocelmesenchymal stem cellsMSC therapyallogeneic cell therapystem cell therapyoff-the-shelf cell therapyCDMO servicesAlzheimer's disease therapyHypoplastic Left Heart SyndromeHLHSAging Frailtyclinical-stage biotechcontract manufacturingpre-revenue biotechGMP manufacturingstem cell manufacturingtissue regeneration

Longeveron Comparables

Compare Longeveron with similar companies based on industry and business-model similarity.

No public comparables are available for Longeveron. Request access to learn about comparables coverage.

Request access

Longeveron Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Mar 25, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Devin Blass

Chief Technology Officer

Executive Team

Longeveron Investors

Notable investors and investment history

Longeveron investors
Investor	Rounds
Janus Henderson Group	Private Placement
Coastlands Capital LP	Private Placement
Kalehua Capital Management	Private Placement
Logos Capital	Private Placement

View all Investors

Longeveron Filings

Explore SEC and related filing metadata, where available.

Longeveron filings preview — column headings only; records require access
Type	Date	Amount Offered	Amount Sold	Filing	Pages	Download

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersUnited States

Employee Range40

Year Founded2014

Last FundingMar 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?